New contact lens aims to correct nearsightedness safely

NCT ID NCT06716385

Completed Disease control Sponsor: Visco Vision Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new silicone hydrogel contact lens (MSiHy) for correcting nearsightedness. 134 adults who already wore contacts were randomly assigned to try either the new lens or a standard monthly lens. The goal was to see if the new lens provides clear vision and is safe to wear.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: MSiHy Silicone Hydrogel Soft Contact Lens
What this could lead to: If successful, this could offer a new, safe, and effective option for daily-wear monthly-disposable contact lenses for people with nearsightedness.
What could go wrong: This is a completed trial with 134 participants, so results are limited. The new lens may not be significantly better than existing lenses, and individual comfort or vision quality may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOPIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

myopia refractive error

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MYOPIA REFRACTIVE ERRORS

Contacts and locations

Locations

Chang Gung Memorial Hospital, Linkou

Taoyuan, Taiwan
MayKay Memorial Hospital

Taipei, 10449, Taiwan
Tri-Service General Hospital

Taipei, 114202, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.